OtherArticle
The Disposition and Metabolism of Naveglitazar, a Peroxisome Proliferator-activated Receptor (PPAR) α-γ dual, γ-dominant agonist in Mice, Rats, and Monkeys
Ping Yi, Chad E. Hadden, William F. Annes, David A. Jackson, Barry C. Peterson, Todd A. Gillespie and Jason T Johnson
Drug Metabolism and Disposition September 29, 2006, DOI: https://doi.org/10.1124/dmd.106.012328
Ping Yi
Chad E. Hadden
William F. Annes
David A. Jackson
Barry C. Peterson
Todd A. Gillespie
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
The Disposition and Metabolism of Naveglitazar, a Peroxisome Proliferator-activated Receptor (PPAR) α-γ dual, γ-dominant agonist in Mice, Rats, and Monkeys
Ping Yi, Chad E. Hadden, William F. Annes, David A. Jackson, Barry C. Peterson, Todd A. Gillespie and Jason T Johnson
Drug Metabolism and Disposition September 29, 2006, DOI: https://doi.org/10.1124/dmd.106.012328
OtherArticle
The Disposition and Metabolism of Naveglitazar, a Peroxisome Proliferator-activated Receptor (PPAR) α-γ dual, γ-dominant agonist in Mice, Rats, and Monkeys
Ping Yi, Chad E. Hadden, William F. Annes, David A. Jackson, Barry C. Peterson, Todd A. Gillespie and Jason T Johnson
Drug Metabolism and Disposition September 29, 2006, DOI: https://doi.org/10.1124/dmd.106.012328
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement